High-Tech Gründerfonds et al. invest €400,000 in Chromotek

Greg Gille
@unquotenews
15 July 2010

Tweet
Facebook
LinkedIn
Google plus
Send to

High-Tech Gründerfonds and Bayern Kapital have provided biotechnology company Chromotek with €400,000.

The investment will fund research and development work, aimed at ensuring successful market entry for Chromotek's technology.

The company, founded in 2008, develops inovative reagents for biomedical research. These are used for biomedical screening processes involved in the R&D for pharmaceutical active ingredients. Chromotek aims at commercialising its first products in 2011.

The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.

If you have any information regarding this transaction, please contact Grégoire Gille on +44 20 7484 9824 or gregoire.gille@incisivemedia.com

Tweet
Facebook
LinkedIn
Google plus
Send to

Funds

Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

05 September 2023

Buyouts

Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

04 September 2023

Exits

Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

04 September 2023

Investments

Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

04 September 2023